Investors & Media : on Data Provided by Refinitiv. Minimum 15 minutes delayed. Intra 3 mo. 6 mo. 1 yr. News Releases Intercept Announces PBC Data Presentations at The International Liver Congress™ 2022 Jun 21, 2022 Intercept Provides Update on NASH Regulatory Timeline Jun 06, 2022 Intercept Announces New Clinical Trial and Real-World Outcomes Data for Ocaliva in PBC Jun 03, 2022 Intercept Announces First Patient Dosed in Phase 2 Study of OCA and Bezafibrate for the Treatment of Primary Biliary Cholangitis May 11, 2022 View all press releases > Recent Events and Presentations Q1 2022 Intercept Pharmaceuticals Earnings Call May 6, 2022 at 8:30 AM EDT Q4 2021 Intercept Pharmaceuticals Earnings Call Mar 2, 2022 at 8:30 AM EST Piper Sandler 33rd Annual Virtual Healthcare Conference Nov 22, 2021 at 10:00 AM EST Jefferies London Healthcare Conference Nov 18, 2021 at 8:00 AM GMT View all events & presentations >
Intercept Announces First Patient Dosed in Phase 2 Study of OCA and Bezafibrate for the Treatment of Primary Biliary Cholangitis May 11, 2022
